MySimplePetLab is a technology company.
MySimplePetLab has raised $5.0M across 1 funding round.
MySimplePetLab has raised $5.0M in total across 1 funding round.
MySimplePetLab has raised $5.0M in total across 1 funding round.
MySimplePetLab's investors include Digitalis Ventures.
MySimplePetLab is a pet health technology company that develops vet-approved at-home testing kits and care products for dogs and cats, targeting common issues like diarrhea, skin infections, and ear problems.[1][2] It serves pet owners, clinics, and retailers by enabling fast diagnostics and relief at home, reducing the need for immediate vet visits while streamlining wellness monitoring; the company has shown strong growth, including a $6M Series A in 2022, retail expansion to Target and Tractor Supply, and lab upgrades.[1][2]
Formerly ClueJay, MySimplePetLab solves pet health accessibility by combining lab tech with consumer-friendly kits available online, in stores, or via clinics, bridging the gap between overwhelmed vets and proactive owners.[1][2][3]
Founded in 2019 by veterinarians including Co-Founder and Chief Lab & Innovation Officer Dr. Dennis Chmiel, DVM, MySimplePetLab emerged from a mission to democratize high-quality pet care through at-home innovation.[1][2] Headquartered in Minneapolis, MN, with leadership there and a lab in Centennial/Denver, CO area (addresses listed as Littleton or East Arapahoe Road), the idea stemmed from vets' recognition that routine testing could start at home for faster results on stool, skin, or ears.[1][2][3]
Early traction included rebranding from ClueJay, a $6M Series A led by Companion Fund in 2022, Target Takeoff Accelerator 2022 win, and Pet Innovation Award 2021; pivotal moments feature lab expansion for direct results to owners and vets, plus care kit launches in 2023.[1][2]
MySimplePetLab rides the pet tech boom, fueled by rising pet humanization, post-pandemic wellness focus, and direct-to-consumer health trends akin to human at-home testing (e.g., 23andMe for pets).[1][2] Timing aligns with vet shortages and demand for telehealth alternatives, as 2022 CEO comments highlighted relief for owners and vets amid overload.[1]
Market forces like e-commerce pet spending growth and lab automation favor it, influencing the ecosystem by outsourcing diagnostics to clinics, enabling retail partnerships, and pushing "automated pet wellness" with tech results sharing—positioning it as a leader in veterinary diagnostics.[2][3]
MySimplePetLab is poised to dominate at-home pet diagnostics with care kit expansions and clinic growth via MySimplePet Express, potentially capturing more retail and vet partnerships amid surging pet care tech adoption.[2][3] Trends like AI-driven labs, subscription wellness, and global pet ownership rises will shape its path, evolving its influence from testing pioneer to full-stack pet health platform.
This builds on its vet-founded edge, making advanced care as simple as a kit—streamlining what started as home tests into everyday pet wellness.
MySimplePetLab has raised $5.0M across 1 funding round. Most recently, it raised $5.0M Series A in October 2022.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Oct 1, 2022 | $5.0M Series A | Digitalis Ventures |